Cart
sales@molnova.com
Gardiquimod
CAS No. 1020412-43-4
Gardiquimod( —— )
Catalog No. M26693 CAS No. 1020412-43-4
Gardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 39 | Get Quote |
|
| 5MG | 61 | Get Quote |
|
| 10MG | 102 | Get Quote |
|
| 25MG | 169 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGardiquimod
-
NoteResearch use only, not for human use.
-
Brief DescriptionGardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells.
-
DescriptionGardiquimod could inhibit HIV-1 infection of macrophages and activated peripheral blood mononuclear cells. Gardiquimod is an imidazoquinoline analog and is a TLR7/8 agonist. When used at concentrations below 10 μM, Gardiquimod specifically activates TLR7.(In Vitro):Administration of 6-60 μM Gardiquimod obviously inhibits HIV-1 reverse transcriptase cDNA synthesis.(In Vivo):Gardiquimod (1 mg/kg per mouse; i.p.; daily for 7 days) in combination with Dendritic cells (DCs) enhance the anti-tumor effects of NK cells.
-
In VitroGardiquimod (6-60?μM ) significantly inhibits cDNA synthesis by HIV-1 reverse transcriptase.
-
In VivoDendritic cells (DCs) in combination with Gardiquimod (1 mg/kg per mouse; i.p.; daily for 7 days) improves the anti-tumor effects of NK cells. Animal Model:Male athymic nude mice (Balb-nu/nu, 5 weeks old) (bearing human HepG2 liver carcinoma xenografts)Dosage:1 mg/kg per mouse Administration:i.p.; daily for 7 days Result:Significantly suppressed the growth of human HepG2 liver carcinoma xenografts.
-
Synonyms——
-
PathwayImmunology/Inflammation
-
TargetTLR
-
RecptorEstrogen Receptor/ERR| Human Endogenous Metabolite
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1020412-43-4
-
Formula Weight313.405
-
Molecular FormulaC17H23N5O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMF : ≥ 20 mg/mL (63.82 mM)DM)
-
SMILESCCNCc1nc2c(N)nc3ccccc3c2n1CC(C)(C)O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Hernández N, et al. 4-Hydroxyestradiol improves mouse embryo quality, epidermal growth factor-binding capability in vitro and implantation rates. Mol Hum Reprod. 2021 Feb 5;27(2):gaaa075.
molnova catalog
related products
-
RS09 2TFA 1449566-36...
RS09 2TFA is a TLR4 agonist.?Promotes NF-κB nuclear translocation and induces inflammatory cytokine secretion in RAW264.7 macrophages in vitro.??It acts as an adjuvant in vivo and enhances X-15 specific antibody serum concentrations.
-
Semapimod hydrochlor...
Semapimod (CNI 1493;AXD-455) is a tetravalent guanylhydrazone that acts as a selective inhibitor of cytokine-inducible arginine transport and NO production.
-
ODN 1826
ODN 1826 is a 20-mer DNA strand, a TLR9 agonist and an immunostimulant, with anti-tumor and cardioprotective effects, promoting apoptosis, and stimulating the production of NO and iNOS. ODN 1826 is a CpG DNA mimetic that can be used as an adjuvant for synthetic vaccines.
